Nearly everything is going right these days for Eli Lilly (NYSE: LLY). Sales and profits have been soaring. So has the share price, jumping more than 50% year to date after a 59% gain in 2023. Lilly now ranks as the biggest healthcare company in the world. The drugmaker has more room to grow, with its ...
motleyfoolusx:llyusx:vrtx
Buying a stock with the intention of never selling it, or perhaps only selling it in a few decades, requires a level of conviction that most investments simply don't warrant. It's not enough to believe that a business is doing well today, or that its management team right now is doing an effective job. ...
motleyfoolusx:vrtx
Have you ever felt anxiety about clicking the final button to buy a stock? Some investors agonize over their decisions. It doesn't have to be that way, though, if you find the right stocks. Three Motley Fool contributors believe they've identified good picks -- and they're all big biotech stocks. Here's ...
motleyfoolusx:llyusx:vrtxusx:nvo
A sum of $500 might not seem like much of an investment, but if you select the right pharmaceutical stocks -- and are patient enough to hold them forever -- history shows you'll have a very high chance of ending up with many times more money than at the start. With that in mind, let's examine three leading ...
motleyfoolusx:vrtx
Vertex Pharmaceuticals (NASDAQ: VRTX) is a fast-growing pharmaceutical company that investors have been bullish on for years. The business generates billions in revenue from cystic fibrosis drugs, and it has been working on diversifying its portfolio to include a wider array of products. Today, the stock ...
motleyfoolusx:vrtx
The stock market has performed relatively well since the beginning of the year although, of course, there is no guarantee that it will maintain that momentum. Who knows what curve ball the future has in store for us? Regardless of what happens, investing in market leaders with robust underlying businesses ...
motleyfoolusx:regnusx:vrtx
What's better than a stock that has delivered huge gains? That's easy: A stock that has delivered huge gains and still has a lot of room to run. We asked three Motley Fool contributors to look among recently high-flying stocks for those that they believe could soar by significantly more. Here's why they ...
motleyfoolusx:llyusx:vrtxusx:nvo
There are several textbook arguments against monopolies. According to one of them, companies that control a market can lower the quality of their products with impunity. However, Vertex Pharmaceuticals (NASDAQ: VRTX), a drugmaker with a monopoly in the cystic fibrosis (CF) market, hasn't done that -- ...
motleyfoolusx:vrtx
The stock market has taken investors for a wild ride these last few years. When you're investing in stocks for many years, though, even multiple tough market cycles shouldn't deter you from your core investing thesis about quality companies. Even as the S&P 500 has had a pretty fantastic 2024 so far, ...
motleyfoolusx:vrtx
